Recent Update on Nanoparticles Based Approaches for Management of Cancer: Wave from Traditional to Advanced Technology.

IF 2.3 4区医学 Q3 ONCOLOGY

Current cancer drug targets Pub Date : 2024-10-25 DOI:10.2174/0115680096323618240911140624

Abhishek Sharma, Mridul Modgil, Gaurav Joshi, Preeti Bisht

{"title":"Recent Update on Nanoparticles Based Approaches for Management of Cancer: Wave from Traditional to Advanced Technology.","authors":"Abhishek Sharma, Mridul Modgil, Gaurav Joshi, Preeti Bisht","doi":"10.2174/0115680096323618240911140624","DOIUrl":null,"url":null,"abstract":"<p><p>Cancer is the second most common cause of death worldwide and one of the biggest public health issues arising day by day. Cancer treatment has experienced significant progres-sions in recent years, as emerging technologies have provided innovative strategies to combat this intricate ailment. Among these developments, nanotechnology has shown itself to be a po-tentially useful tool in the fight against cancer. In the last few years, there have been several re-searches performed in the field of nanoparticles because of their several advantages as compared to conventional drug delivery using nanoparticles along with updating technologies like artificial intelligence (AI). The use of nanoparticles decreases the chance of undesirable side effects and shows its action on the targeted site with the help of designed carriers.AI based nanoparticles can't only be used for achieving the targeted site of action but can also help us in advanced im-aging, drug release and optimizing the drug delivery in a more customized way, which opens the door of a new era for tailored made medicine.</p>","PeriodicalId":10816,"journal":{"name":"Current cancer drug targets","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current cancer drug targets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115680096323618240911140624","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Cancer is the second most common cause of death worldwide and one of the biggest public health issues arising day by day. Cancer treatment has experienced significant progres-sions in recent years, as emerging technologies have provided innovative strategies to combat this intricate ailment. Among these developments, nanotechnology has shown itself to be a po-tentially useful tool in the fight against cancer. In the last few years, there have been several re-searches performed in the field of nanoparticles because of their several advantages as compared to conventional drug delivery using nanoparticles along with updating technologies like artificial intelligence (AI). The use of nanoparticles decreases the chance of undesirable side effects and shows its action on the targeted site with the help of designed carriers.AI based nanoparticles can't only be used for achieving the targeted site of action but can also help us in advanced im-aging, drug release and optimizing the drug delivery in a more customized way, which opens the door of a new era for tailored made medicine.

查看原文本刊更多论文

基于纳米粒子的癌症治疗方法的最新进展：从传统技术到先进技术的浪潮。

癌症是全球第二大常见死因，也是与日俱增的最大公共卫生问题之一。近年来，癌症治疗取得了重大进展，因为新兴技术为抗击这一复杂疾病提供了创新策略。在这些发展中，纳米技术已成为抗癌的潜在有用工具。在过去的几年里，纳米颗粒领域进行了多项重新研究，因为与传统的给药方式相比，纳米颗粒与人工智能（AI）等最新技术一起具有多种优势。基于人工智能的纳米颗粒不仅可用于实现目标作用部位，还能帮助我们进行先进的成像、药物释放，并以更个性化的方式优化给药，这为量身定制的医药打开了新时代的大门。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current cancer drug targets 医学-肿瘤学

CiteScore

5.40

自引率

0.00%

发文量

105

审稿时长

1 months

期刊介绍： Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes. Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer. As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.